AI-based protein discovery start-up strikes a second deal with Takeda
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAI-based protein discovery start-up strikes a second deal with Takeda